198 related articles for article (PubMed ID: 29959065)
1. LncRNA THOR attenuates cisplatin sensitivity of nasopharyngeal carcinoma cells via enhancing cells stemness.
Gao L; Cheng XL; Cao H
Biochimie; 2018 Sep; 152():63-72. PubMed ID: 29959065
[TBL] [Abstract][Full Text] [Related]
2. LncRNA THOR increases the stemness of gastric cancer cells via enhancing SOX9 mRNA stability.
Song H; Xu Y; Shi L; Xu T; Fan R; Cao M; Xu W; Song J
Biomed Pharmacother; 2018 Dec; 108():338-346. PubMed ID: 30227327
[TBL] [Abstract][Full Text] [Related]
3. The Long Non-Coding RNA MALAT1 Enhances Ovarian Cancer Cell Stemness by Inhibiting YAP Translocation from Nucleus to Cytoplasm.
Wu X; Wang Y; Zhong W; Cheng H; Tian Z
Med Sci Monit; 2020 May; 26():e922012. PubMed ID: 32433460
[TBL] [Abstract][Full Text] [Related]
4. LncRNA B4GALT1-AS1 recruits HuR to promote osteosarcoma cells stemness and migration via enhancing YAP transcriptional activity.
Li Z; Wang Y; Hu R; Xu R; Xu W
Cell Prolif; 2018 Dec; 51(6):e12504. PubMed ID: 30182452
[TBL] [Abstract][Full Text] [Related]
5. lncRNA B4GALT1-AS1 promotes colon cancer cell stemness and migration by recruiting YAP to the nucleus and enhancing YAP transcriptional activity.
Zhang Y; Fang Z; Guo X; Dong H; Zhou K; Huang Z; Xiao Z
J Cell Physiol; 2019 Aug; 234(10):18524-18534. PubMed ID: 30912138
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of mitochondrial cyclooxygenase-2 inhibits the stemness of nasopharyngeal carcinoma by decreasing the activity of dynamin-related protein 1.
Zhou TJ; Zhang SL; He CY; Zhuang QY; Han PY; Jiang SW; Yao H; Huang YJ; Ling WH; Lin YC; Lin ZN
Theranostics; 2017; 7(5):1389-1406. PubMed ID: 28435473
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of HuR represses osteosarcoma cells migration, invasion and stemness through inhibition of YAP activation and increases susceptibility to chemotherapeutic agents.
Xu W; Chen C; Xu R; Li Y; Hu R; Li Z; Zhu X
Biomed Pharmacother; 2018 Jun; 102():587-593. PubMed ID: 29597092
[TBL] [Abstract][Full Text] [Related]
8. Triptonide inhibits human nasopharyngeal carcinoma cell growth via disrupting Lnc-RNA THOR-IGF2BP1 signaling.
Wang SS; Lv Y; Xu XC; Zuo Y; Song Y; Wu GP; Lu PH; Zhang ZQ; Chen MB
Cancer Lett; 2019 Feb; 443():13-24. PubMed ID: 30503558
[TBL] [Abstract][Full Text] [Related]
9. A directly negative interaction of miR-203 and ZEB2 modulates tumor stemness and chemotherapy resistance in nasopharyngeal carcinoma.
Jiang Q; Zhou Y; Yang H; Li L; Deng X; Cheng C; Xie Y; Luo X; Fang W; Liu Z
Oncotarget; 2016 Oct; 7(41):67288-67301. PubMed ID: 27589832
[TBL] [Abstract][Full Text] [Related]
10. LncRNA
Wu H; He Y; Chen H; Liu Y; Wei B; Chen G; Lin H; Lin H
FEBS Open Bio; 2019 Apr; 9(4):781-790. PubMed ID: 30984551
[TBL] [Abstract][Full Text] [Related]
11. Crucifera sulforaphane (SFN) inhibits the growth of nasopharyngeal carcinoma through DNA methyltransferase 1 (DNMT1)/Wnt inhibitory factor 1 (WIF1) axis.
Chen L; Chan LS; Lung HL; Yip TTC; Ngan RKC; Wong JWC; Lo KW; Ng WT; Lee AWM; Tsao GSW; Lung ML; Mak NK
Phytomedicine; 2019 Oct; 63():153058. PubMed ID: 31394414
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of lncRNA XIST inhibits hypoxia-induced glycolysis, migration and invasion through regulating miR-381-3p/NEK5 axis in nasopharyngeal carcinoma.
Zhao CH; Bai XF; Hu XH
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2505-2517. PubMed ID: 32196601
[TBL] [Abstract][Full Text] [Related]
13. LncRNA SNHG6 accelerates nasopharyngeal carcinoma progression via modulating miR-26a-5p/ARPP19 axis.
Yin X; Gu X; Li F; Ye F; Liu F; Wang W
Bioorg Med Chem Lett; 2021 May; 40():127955. PubMed ID: 33744438
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of long non-coding RNA TUG1 suppresses nasopharyngeal carcinoma progression by inhibiting epithelial-mesenchymal transition (EMT) via the promotion of miR-384.
Qian W; Ren Z; Lu X
Biochem Biophys Res Commun; 2019 Jan; 509(1):56-63. PubMed ID: 30581000
[TBL] [Abstract][Full Text] [Related]
15. The long non-coding RNA MACC1-AS1 promotes nasopharyngeal carcinoma cell stemness via suppressing miR-145-mediated inhibition on SMAD2/MACC1-AS1 axis.
Chen S; Luo X; Wu W; Li Y; Yu H; Wang Y; Yan J
Biomed Pharmacother; 2020 May; 125():109986. PubMed ID: 32058221
[TBL] [Abstract][Full Text] [Related]
16. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
[No Abstract] [Full Text] [Related]
17. Downregulation of lncRNA ANRIL represses tumorigenicity and enhances cisplatin-induced cytotoxicity via regulating microRNA let-7a in nasopharyngeal carcinoma.
Wang Y; Cheng N; Luo J
J Biochem Mol Toxicol; 2017 Jul; 31(7):. PubMed ID: 28117929
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA NPCCAT1 promotes nasopharyngeal carcinoma progression via upregulating YY1.
Su H; Liu L; Zhang Y; Wang J; Zhao Y
Biochimie; 2019 Feb; 157():184-194. PubMed ID: 30481541
[TBL] [Abstract][Full Text] [Related]
19. Epithelial cell adhesion molecule overexpression regulates epithelial-mesenchymal transition, stemness and metastasis of nasopharyngeal carcinoma cells via the PTEN/AKT/mTOR pathway.
Wang MH; Sun R; Zhou XM; Zhang MY; Lu JB; Yang Y; Zeng LS; Yang XZ; Shi L; Xiao RW; Wang HY; Mai SJ
Cell Death Dis; 2018 Jan; 9(1):2. PubMed ID: 29305578
[TBL] [Abstract][Full Text] [Related]
20. TIMELESS confers cisplatin resistance in nasopharyngeal carcinoma by activating the Wnt/β-catenin signaling pathway and promoting the epithelial mesenchymal transition.
Liu SL; Lin HX; Lin CY; Sun XQ; Ye LP; Qiu F; Wen W; Hua X; Wu XQ; Li J; Song LB; Guo L
Cancer Lett; 2017 Aug; 402():117-130. PubMed ID: 28583847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
